Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01666405 · ClinicalTrials.gov registry record · Phase 1
Prospective, Multicenter Trial to Investigate the Safety and Efficacy of Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence
A Phase 1 study, sponsored by Uroplasty.
- Terminated
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT01666405 is a Phase 1 study that was terminated before completion, run by Uroplasty. The registered enrollment target is 30 participants.
The verdict
NCT01666405, a Phase 1 study, was terminated before completion, sponsored by Uroplasty.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness of percutaneous tibial nerve stimulation (PTNS) therapy with the Urgent® PC Neuromodulation System (Uroplasty, Inc., Minnetonka, MN, USA) for the treatment of fecal incontinence (FI).
Interventions
- DEVICE Urgent(R) PC Neuromodulation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01666405
The ClinicalTrials.gov registry entry for NCT01666405 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Uroplasty, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Urgent(R) PC Neuromodulation System is the first listed.
NCT01666405 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01666405 about?
NCT01666405 is a clinical study titled "Prospective, Multicenter Trial to Investigate the Safety and Efficacy of Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence". The purpose of this study is to determine the effectiveness of percutaneous tibial nerve stimulation (PTNS) therapy with the Urgent® PC Neuromodulation System (Uroplasty, Inc., Minnetonka, MN, USA) for the treatment of fecal incontinence (FI).
What is the current status of trial NCT01666405?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2012-08. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01666405?
The interventions under investigation include: Urgent(R) PC Neuromodulation System (DEVICE).
Who is sponsoring clinical trial NCT01666405?
This trial is sponsored by Uroplasty, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.